ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Efthimiadis, A.
Right arrow Articles by Hargreave, F.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Efthimiadis, A.
Right arrow Articles by Hargreave, F.E.
Eur Respir J 2002; 19:706-708
Copyright ©ERS Journals Ltd 2002


Induced sputum: time from expectoration to processing

A. Efthimiadis, L. Jayaram, S. Weston, S. Carruthers and F.E. Hargreave

Asthma Research Group, Firestone Institute for Respiratory Health, St Joseph's Healthcare and McMaster University, Hamilton, Ontario, Canada

CORRESPONDENCE: F.E. Hargreave, Firestone Institute for Respiratory Health, St. Joseph's Healthcare, 50 Charlton Ave. East, Hamilton, ON, Canada, L8N 4A6. Fax: 1 9055216158. E-mail: hargreav@mcmaster.ca

Keywords: induced sputum, sputum cell counts, sputum chemistry

Received: December 12, 2000
Accepted November 16, 2001

This study was supported by a Medical School Grant from Merck Frosst Inc.


    Abstract
 TOP
 Abstract
 Methods
 Results
 Discussion
 Acknowledgements
 References
 
One of the limitations in the use of induced sputum to measure indices of airway inflammation is the perceived need to process the sample within 2 h. Therefore, the authors investigated whether the processing of induced sputum could be delayed.

Induced sputum samples obtained from asthmatic subjects (n=30) were examined. Each sample was stored at 4°C. A portion was selected and processed within 2 h and the remaining expectorate (sputum plus saliva) was refrigerated. Later an equal amount was selected and processed at either 9 (n=15) or 18 (n=15) h. The sputum was examined for cell counts and viability, fluid-phase eosinophil cationic protein (ECP), interleukin-8 (IL-8) and fibrinogen. Repeatability of measurements was assessed by the interclass correlation coefficient (ICC).

Measurements obtained at 9 h did not differ from those made at 2 h and the repeatability was excellent (ICC 0.88–0.99). However, by 18 h the median cell viability was reduced from 65.0% to 43.0% and the ICC was generally lower: 0.10 for total cell count, 0.24 for viability, 0.60 for neutrophils, 0.90 for eosinophils, 0.56 for macrophages, 0.76 for ECP, 0.82 for IL-8 and 0.84 for fibrinogen.

The results indicate that when induced sputum from subjects with asthma is kept at 4°C, examination of cell counts can be delayed for <=9 h and for the fluid-phase indices measured for <=18 h. Further investigation of this issue is required for spontaneous sputum, other airway diseases and other inflammatory markers.

The value of sputum examination in research is established and there is increasing evidence that it might have a place in clinical practice 1. One limitation of its use is the perceived need to process it within 2 h of collection. Sputum examination was therefore investigated in order to determine whether it could be delayed for longer without compromising the reproducibility of the total cell count, viability, eosinophils, neutrophils, macrophages and fluid-phase eosinophil cationic protein (ECP), interleukin (IL)-8 and fibrinogen.


    Methods
 TOP
 Abstract
 Methods
 Results
 Discussion
 Acknowledgements
 References
 
Subjects
Subjects with asthma (n=30) attended the Firestone Institute for Respiratory Health (table 1Go). The diagnosis of asthma was based on episodic symptoms of wheeze and dyspnoea with variable airflow limitation within the past year. The latter was indicated by an improvement in baseline forced expiratory volume in one second (FEV1) of ≥12% 10 min after salbutamol (200 µg) if the FEV1/slow vital capacity was ≥70%, or by airway hyperresponsiveness to methacholine (expressed as the provocative concentration causing a 20% fall in FEV1 (PC20) <8 mg·mL–1 if it was >70%. The study was approved by the hospital's Research Ethics Board.


View this table:
[in this window]
[in a new window]
 
Table 1— Patient characteristics

 
Study design
An expectorate of sputum plus saliva was induced and stored at 4°C until examined. One portion was selected and examined within 2 h and the remaining expectorate was coded and refrigerated at 4°C. At 9 h in 15 subjects or 18 h in the other 15, an equal amount was selected and examined. Examination of each sample was performed by one of two technologists blinded to each other, who had a high interobserver repeatability of sputum cell counts 2. Fluid-phase measurements were performed on coded samples by one observer.

Sputum induction and examination
Sputum was induced, selected and processed as described previously 3. The total cell count and viability were obtained simultaneously in a modified Neubauer counting chamber (Hausser Scientific, Horsham, PA, USA). Cytospins were prepared, stained with Wright's and a 400 nonsquamous differential cell count was obtained. Cell morphology was assessed by grading preservation of the cell outline as described previously 3. The change from the corresponding <2-h sample was determined by a score of zero and one for change and no change, respectively. The remaining cell suspension was centrifuged at 790xg for 4 min and the supernatant was aspirated and stored at –70°C for later analysis of ECP, IL-8 and fibrinogen. The concentration of ECP (µg·L–1) in the thawed supernatant was determined using a sensitive radioimmunoassay (Pharmacia and Upjohn, Uppsala, Sweden), IL-8 (pg·mL–1) was determined by enzyme-linked immunosorbent assay (ELISA) (Amersham Pharmacia Biotech, Mississauga, ON, Canada) and fibrinogen (ng·mL1) was measured by a "sandwich" ELISA using a rabbit antihuman fibrinogen antibody (Dako A080; Dako Diagnostics, Mississauga, ON, Canada). The results were adjusted for dilution.

Analysis
Descriptive statistics were used to summarize clinical characteristics. PC20 data were log transformed and reported as geometric mean and geometric sd. The effect of time on the outcome measures was compared with a multivariate analysis of variance, and the source of significant variation was identified using Newman-Keuls post hoc analysis. Reliability of measurements was assessed by the intraclass correlation coefficient and, based on previous studies, values of ≥0.80 were considered to be acceptable for cell counts 4.


    Results
 TOP
 Abstract
 Methods
 Results
 Discussion
 Acknowledgements
 References
 
Measurements obtained at 9 h did not differ from those obtained at 2 h (p>0.05 for each comparison) (table 2Go). However, by 18 h there was a significant reduction in cell viability (median 71.0 versus 69.0 within 2–9 h compared with 65.0 versus 43.0 within 2–18 h), and post hoc analysis showed a significant difference between the <2 h and 18 h samples (p<0.001). There was also evidence of morphology changes due to lysis in 50% of the 18 h samples and one was uncountable.


View this table:
[in this window]
[in a new window]
 
Table 2— Repeatability of sputum cell counts and fluid-2 phase measurements

 
Fluid-phase measurements of ECP, IL-8, and fibrinogen were not significantly different (p>0.05) between induced sputum processed within 2–9 h or those processed within 2–18 h (table 2Go).


    Discussion
 TOP
 Abstract
 Methods
 Results
 Discussion
 Acknowledgements
 References
 
The results of this study suggest that the examination of induced sputum can be delayed for <=9 h, without altering the total cell count, viability, differential cell count and morphology. Fluid-phase ECP, IL-8 and fibrinogen may be delayed for <=18 h. These findings are relevant to laboratory logistics.

This is the first study to determine whether the repeatability of inflammatory cell counts and fluid-phase measurements in induced sputum can be maintained for >2 h when stored at 4°C. The processing of sputum and examination of the cells is a lengthy process, which varies between 1–2 h based on the availability of automated staining methods and experienced personnel. The current 2 h time constraint between expectoration and processing places a limitation on the number of samples that can be processed in parallel and restricts the use of the method outside of research centres. The decision to refrigerate and examine cells at 9 and 18 h was for practical reasons. Refrigeration is commonly used to store biological fluids pending analysis, and studies in blood have confirmed that it improves the stability of the differential cell count compared to storage at room temperature 5. A previous in-house pilot study (unpublished data) suggested that refrigeration of the entire expectorate for 7 h did not have an adverse affect on cell counts and morphology, while at 24 h most of the cells were damaged and unrecognizable. Therefore, examination at 9 h was considered to be reasonable for a working day and at 18 h to facilitate morning examination of samples arriving in the laboratory in the late afternoon.

The study findings of excellent reproducibility of measurements at 9 h was associated with preserved cell viability and morphology and deterioration in the cell counts at 18 h was observed. Although the fluid-phase measurements of eosinophil cationic protein, interleukin-8, and fibrinogen also changed at 18 h this was not as profound. It should be realized, however, that these results are limited to induced sputum stored at 4°C from subjects with asthma. Further study is required for spontaneously expectorated sputum, other airway diseases and other indices of airway inflammation.


    Acknowledgements
 TOP
 Abstract
 Methods
 Results
 Discussion
 Acknowledgements
 References
 
The authors thank the subjects who volunteered to help with the study, and M. Inman and M. Pizzichini for statistical advice.


    References
 TOP
 Abstract
 Methods
 Results
 Discussion
 Acknowledgements
 References
 

  1. Jayaram L, Parameswaran K, Sears MR, Hargreave FE. Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J 2000;16:150–158.[Abstract]
  2. Pizzichini E, Leff JA, Reiss TF, et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J 1999;14:12–18.[Abstract]
  3. Pizzichini E, Pizzichini MMM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J 1996;9:1174–1180.[Abstract]
  4. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid phase measurements. Am J Respir Crit Care Med 1996;154:308–317.[Abstract]
  5. Wood BL, Andrews J, Miller S, Sabath DE. Refrigerated storage improves the stability of the complete blood cell count and automated differential. Am J Clin Pathol 1999;112:687–695.[Web of Science][Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
ChestHome page
T. D. Mickleborough, M. R. Lindley, A. A. Ionescu, and A. D. Fly
Protective Effect of Fish Oil Supplementation on Exercise-Induced Bronchoconstriction in Asthma
Chest, January 1, 2006; 129(1): 39 - 49.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Prince, M. Bertrand, M.-E. Boulay, M.-C. Bernier, and L.-P. Boulet
Optimization of the Conditions for Preservation of Induced Sputum: Influence of Freezing on Cellular Analysis
Chest, August 1, 2005; 128(2): 980 - 985.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M.M. Kelly, F.E. Hargreave, and G. Cox
A method to preserve sputum for delayed examination
Eur. Respir. J., December 1, 2003; 22(6): 996 - 1000.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Efthimiadis, A.
Right arrow Articles by Hargreave, F.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Efthimiadis, A.
Right arrow Articles by Hargreave, F.E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS